Gene · 7306
Papers3,635
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 3,635
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Ginsenoside Rh2 attenuates the progression of non-small cell lung cancer by sponging miR-28-5p/STK4 axis and inactivating Wnt/β-catenin signaling. | Cancer Med | 2023 | 37081781 | PubTator, text mining | PubMed |
| Human CEACAM1 is targeted by a Streptococcus pyogenes adhesin implicated in puerperal sepsis pathogenesis. | Nat Commun | 2023 | 37080973 | PubTator, text mining | PubMed |
| Pigmentation and TYRP1 expression are mediated by zinc through the early secretory pathway-resident ZNT proteins. | Commun Biol | 2023 | 37072620 | PubTator, text mining | PubMed |
| The anti-melanogenic properties of Swietenia macrophylla king. | Biomed Pharmacother | 2023 | 37068335 | PubTator, text mining | PubMed |
| The regulatory role of microRNAs in common eye diseases: A brief review. | Front Genet | 2023 | 37065488 | PubTator, text mining | PubMed |
| Evaluating the Application Potential of a Recombinant Ganoderma Protein as Bioactive Ingredients in Cosmetics. | Molecules | 2023 | 37050035 | PubTator, text mining | PubMed |
| Cracking the Code of Neuronal Cell Fate. | Cells | 2023 | 37048129 | PubTator, text mining | PubMed |
| Generating Functional and Highly Proliferative Melanocytes Derived from Human Pluripotent Stem Cells: A Promising Tool for Biotherapeutic Approaches to Treat Skin Pigmentation Disorders. | Int J Mol Sci | 2023 | 37047372 | PubTator, text mining | PubMed |
| Neurog1-Derived Peptides RMNE1 and DualPep-Shine Penetrate the Skin and Inhibit Melanin Synthesis by Regulating MITF Transcription. | Int J Mol Sci | 2023 | 37047130 | PubTator, text mining | PubMed |
| Melatonin inhibits senescence-associated melanin pigmentation through the p53-TYR pathway in human primary melanocytes and the skin of C57BL/6 J mice after UVB irradiation. | J Mol Med (Berl) | 2023 | 37032347 | PubTator, text mining | PubMed |
| Tumour-derived extracellular vesicle based vaccines for melanoma treatment. | Drug Deliv Transl Res | 2023 | 37022605 | PubTator, text mining | PubMed |
| Pigment cell progenitor heterogeneity and reiteration of developmental signaling underlie melanocyte regeneration in zebrafish. | Elife | 2023 | 37021774 | PubTator, text mining | PubMed |
| Integrative Single-Cell Transcriptomics and Epigenomics Mapping of the Fetal Retina Developmental Dynamics. | Adv Sci (Weinh) | 2023 | 37017569 | PubTator, text mining | PubMed |
| Expression Signature of Immune-Related MicroRNAs in Autoimmune Skin Disease: Psoriasis and Vitiligo Insights. | Mol Diagn Ther | 2023 | 37016095 | PubTator, text mining | PubMed |
| Effects of greater erythroid Cl-/HCO3- transporter (band 3) expression on ventilation and gas exchange during exhaustive exercise. | Am J Physiol Lung Cell Mol Physiol | 2023 | 37014821 | PubTator, text mining | PubMed |
| Oculocutaneous albinism: the neurological, behavioral, and neuro-ophthalmological perspective. | Eur J Pediatr | 2023 | 37009951 | PubTator, text mining | PubMed |
| Targeting myeloid-derived suppressor cells in tumor immunotherapy: Current, future and beyond. | Front Immunol | 2023 | 37006306 | PubTator, text mining | PubMed |
| Mass Spectral Analyses of Salmonella Myovirus SPN3US Reveal Conserved and Divergent Themes in Proteolytic Maturation of Large Icosahedral Capsids. | Viruses | 2023 | 36992431 | PubTator, text mining | PubMed |
| Application of DNA Replicons in Gene Therapy and Vaccine Development. | Pharmaceutics | 2023 | 36986808 | PubTator, text mining | PubMed |
| Structure-Based Virtual Screening of Furan-1,3,4-Oxadiazole Tethered N-phenylacetamide Derivatives as Novel Class of hTYR and hTYRP1 Inhibitors. | Pharmaceuticals (Basel) | 2023 | 36986444 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/7306/papers?page=17